久光製薬の業績推移
(単位:百万円)
|
売上高 |
営業利益 |
経常利益 |
純利益 |
売上原価 |
売上総利益 |
株主資本 |
総負債 |
総資産 |
現金及び現金同等物 |
流動市場性有価証券 |
流動資産 |
流動負債 |
利益剰余金 |
営業利益率 |
経常利益率 |
当期利益率 |
自己資本比率 |
営業キャッシュフロー |
投資キャッシュフロー |
財務キャッシュフロー |
営業キャッシュフローマージン |
フリーキャッシュフロー |
ROE |
ROA |
一株あたり利益 |
希薄化後一株あたり利益 |
従業員数 |
2024年2月
|
141,706
|
13,167
|
19,649
|
14,431
|
62,735
|
78,971
|
267,082
|
61,697
|
328,779
|
112,459
|
|
194,022
|
45,938
|
242,578
|
9.29%
|
13.87%
|
10.18%
|
81.23%
|
18,188
|
-2,512
|
-16,691
|
12.84%
|
15,676
|
5.49%
|
4.49%
|
0.00018162
|
0.00018142
|
2759人
|
2023年2月
|
128,330
|
11,599
|
16,051
|
12,126
|
55,630
|
72,700
|
258,408
|
55,509
|
313,917
|
122,154
|
|
199,174
|
42,578
|
235,569
|
9.04%
|
12.51%
|
9.45%
|
82.32%
|
12,727
|
-23,868
|
-14,687
|
9.92%
|
-11,141
|
4.72%
|
3.93%
|
0.00014801
|
0.00014788
|
2769人
|
2022年2月
|
120,193
|
9,337
|
12,638
|
9,862
|
50,126
|
70,067
|
254,885
|
47,973
|
302,858
|
129,290
|
|
200,176
|
32,160
|
236,192
|
7.77%
|
10.51%
|
8.21%
|
84.16%
|
19,199
|
-13,060
|
-15,189
|
15.97%
|
6,139
|
3.88%
|
3.27%
|
0.00011892
|
0.00011884
|
2784人
|
2021年2月
|
114,510
|
10,671
|
11,829
|
9,433
|
45,337
|
69,173
|
253,809
|
46,052
|
299,861
|
114,254
|
|
198,061
|
30,057
|
233,376
|
9.32%
|
10.33%
|
8.24%
|
84.64%
|
5,289
|
7,815
|
-7,187
|
4.62%
|
13,104
|
3.74%
|
3.11%
|
0.00011322
|
0.00011311
|
2770人
|
2020年2月
|
140,992
|
22,727
|
25,628
|
18,911
|
53,388
|
87,604
|
250,746
|
56,655
|
307,401
|
107,051
|
|
209,251
|
41,055
|
230,929
|
16.12%
|
18.18%
|
13.41%
|
81.57%
|
27,395
|
-17,229
|
-11,726
|
19.43%
|
10,166
|
7.57%
|
6.25%
|
0.00022758
|
0.0002273
|
2745人
|
2019年2月
|
143,408
|
22,278
|
24,647
|
19,378
|
54,727
|
88,681
|
248,629
|
48,883
|
297,512
|
110,283
|
|
191,418
|
30,354
|
249,156
|
15.53%
|
17.19%
|
13.51%
|
83.57%
|
15,772
|
-39,302
|
-13,347
|
11.0%
|
-23,530
|
7.85%
|
6.49%
|
0.00023008
|
0.00022986
|
2792人
|
2018年2月
|
148,466
|
26,940
|
28,245
|
19,327
|
55,688
|
92,778
|
245,227
|
54,686
|
299,913
|
117,189
|
|
190,065
|
34,938
|
236,342
|
18.15%
|
19.02%
|
13.02%
|
81.77%
|
30,453
|
-1,378
|
-7,153
|
20.51%
|
29,075
|
8.15%
|
6.68%
|
0.00022852
|
0.00022835
|
2823人
|
2017年2月
|
145,962
|
26,306
|
28,179
|
20,541
|
53,155
|
92,807
|
229,205
|
49,615
|
278,820
|
80,280
|
|
172,097
|
32,425
|
224,214
|
18.02%
|
19.31%
|
14.07%
|
82.21%
|
19,910
|
1,070
|
-18,402
|
13.64%
|
20,980
|
9.02%
|
7.29%
|
0.00024127
|
0.00024115
|
2751人
|
2016年2月
|
161,895
|
27,730
|
28,008
|
17,929
|
58,319
|
103,576
|
226,095
|
58,859
|
284,954
|
81,584
|
|
171,760
|
40,997
|
210,725
|
17.13%
|
17.3%
|
11.07%
|
79.34%
|
30,923
|
-3,912
|
-11,616
|
19.1%
|
27,011
|
8.0%
|
6.29%
|
0.00020881
|
0.00020876
|
2900人
|
2015年2月
|
156,791
|
20,527
|
28,489
|
18,784
|
57,063
|
99,728
|
222,054
|
63,386
|
285,440
|
71,298
|
|
165,315
|
44,299
|
199,990
|
13.09%
|
18.17%
|
11.98%
|
77.79%
|
23,232
|
-8,945
|
-7,036
|
14.82%
|
14,287
|
8.98%
|
6.99%
|
0.00021928
|
0.00021928
|
2942人
|
2014年2月
|
150,635
|
19,123
|
28,910
|
21,357
|
55,471
|
95,164
|
196,308
|
55,544
|
251,852
|
66,307
|
|
139,107
|
41,745
|
187,846
|
12.69%
|
19.19%
|
14.18%
|
77.95%
|
35,845
|
-5,843
|
-6,476
|
23.8%
|
30,002
|
11.73%
|
9.17%
|
0.0002493
|
0.0002493
|
2949人
|
2013年2月
|
142,772
|
25,326
|
33,051
|
18,809
|
51,659
|
91,113
|
167,933
|
46,208
|
214,141
|
41,157
|
|
107,719
|
34,385
|
172,488
|
17.74%
|
23.15%
|
13.17%
|
78.42%
|
32,485
|
-7,946
|
-9,288
|
22.75%
|
24,539
|
11.86%
|
9.24%
|
0.00021956
|
0.00021956
|
2826人
|
2012年2月
|
137,794
|
|
33,494
|
18,439
|
|
|
149,263
|
43,575
|
192,838
|
34,222
|
|
|
|
|
0.0%
|
24.31%
|
13.38%
|
77.4%
|
25,558
|
-15,473
|
-13,010
|
18.55%
|
10,085
|
|
|
0.00021509
|
0.00021509
|
2718人
|
2011年2月
|
137,184
|
|
33,236
|
20,956
|
|
|
|
|
|
|
|
|
|
|
0.0%
|
24.23%
|
15.28%
|
|
|
|
|
|
|
|
|
0.0002418
|
0.0002418
|
2635人
|
2010年2月
|
129,834
|
|
31,231
|
18,423
|
|
|
|
|
|
|
|
|
|
|
0.0%
|
24.05%
|
14.19%
|
|
|
|
|
|
|
|
|
0.00021078
|
0.00021078
|
2562人
|